- Home
- OM
as 01-23-2025 3:41pm EST
Outset Medical Inc is a medical technology company. It has developed a machine, Tablo, which reduces the cost and complexity of dialysis. Tablo provides Renal Replacement Therapy in Hospitals, Chronic Care in Dialysis Clinics and Home Dialysis.
| Founded: | 2003 | Country: | United States |
| Employees: | N/A | City: | SAN JOSE |
| Market Cap: | 44.0M | IPO Year: | 2020 |
| Target Price: | $4.00 | AVG Volume (30 days): | 1.5M |
| Analyst Decision: | Strong Buy | Number of Analysts: | 3 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -2.75 | EPS Growth: | N/A |
| 52 Week Low/High: | $0.43 - $5.22 | Next Earning Date: | 02-19-2025 |
| Revenue: | $114,729,000 | Revenue Growth: | -13.00% |
| Revenue Growth (this year): | -11.33% | Revenue Growth (next year): | 10.49% |
Stock Insider Trading Activity of Outset Medical Inc. (OM)
| Name | Ticker | Relationship | Date | Transaction | AVG Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| Ahmed Nabeel | OM | Chief Financial Officer | Jan 17 '25 | Sell | $0.80 | 34,288 | $27,430.40 | 262,776 | |
| Trigg Leslie | OM | Chair and CEO | Jan 17 '25 | Sell | $0.80 | 65,236 | $52,188.80 | 914,029 | |
| Trigg Leslie | OM | Chair and CEO | Jan 13 '25 | Sell | $0.81 | 33,227 | $26,913.87 | 914,029 | |
| Brottem John L. | OM | General Counsel | Jan 13 '25 | Sell | $0.81 | 20,492 | $16,598.52 | 205,028 | |
| Nash Marc | OM | SVP Operations and R&D | Jan 7 '25 | Sell | $1.29 | 720 | $928.80 | 237,302 | |
| Ahmed Nabeel | OM | Chief Financial Officer | Jan 7 '25 | Sell | $1.29 | 1,835 | $2,367.15 | 262,776 | |
| Trigg Leslie | OM | Chair and CEO | Jan 7 '25 | Sell | $1.29 | 10,227 | $13,192.83 | 914,029 | |
| Brottem John L. | OM | General Counsel | Jan 7 '25 | Sell | $1.29 | 1,572 | $2,027.88 | 205,028 | |
| Nash Marc | OM | SVP Operations and R&D | Nov 15 '24 | Sell | $0.80 | 1,375 | $1,100.00 | 237,302 | |
| Ahmed Nabeel | OM | Chief Financial Officer | Nov 15 '24 | Sell | $0.80 | 4,221 | $3,376.80 | 262,776 |
Latest Outset Medical Inc. News
OM Breaking Stock News: Dive into OM Ticker-Specific Updates for Smart Investing
GlobeNewswire
15 days ago
Outset Medical to Present at the 43rd Annual J.P. Morgan Healthcare Conference
MedTech Dive
16 days ago
Outset Medical to pay down debt after raising nearly $300M
MT Newswires
17 days ago
Outset Medical to Raise $169 Million From Private Placement
GlobeNewswire
17 days ago
Outset Medical Announces $169 Million Private Placement Financing From Leading Mutual Funds and Healthcare Institutional Investors
GlobeNewswire
2 months ago
Outset Medical to Present at the 2024 Stifel Healthcare Conference
Insider Monkey
2 months ago
Outset Medical (OM) Slipped on Earnings Miss and Reduced Guidance
Simply Wall St.
2 months ago
Outset Medical Third Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags
GuruFocus.com
3 months ago
Outset Medical Inc (OM) Q3 2024 Earnings Call Highlights: Navigating Growth Amidst Challenges
Compare OM vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "OM Outset Medical Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.